Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression

Andrea Paradisi, Carine Maisse, Marie May Coissieux, Nicolas Gadot, Florian Lépinasse, Céline Delloye-Bourgeois, Jean Guy Delcros, Magali Svrcek, Clemens Neufert, Jean François Fléjou, Jean Yves Scoazec, Patrick Mehlen

    Research output: Contribution to journalArticlepeer-review

    95 Citations (Scopus)

    Abstract

    Chronic inflammation and cancer are intimately associated. This is particularly true for inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease, which show a major increased risk for colorectal cancer. While the understanding of the molecular pathogenesis of IBD has recently improved, the mechanisms that link these chronic inflammatory states to colorectal cancer development are in large part unknown. One of these mechanisms is NF-κB pathway activation which in turn may contribute to tumor formation by providing anti-apoptotic survival signals to the epithelial cells. Based on the observation that netrin-1, the anti-apoptotic ligand for the dependence receptors DCC and UNC5H is up-regulated in colonic crypts in response to NF-κB, we show here that colorectal cancers from inflammatory bowel diseases patients have selected up-regulation of netrin-1. Moreover, we demonstrate that this inflammation-driven netrin-1 up-regulation is causal for colorectal cancer development as interference with netrin-1 autocrine loop in a mouse model for ulcerative colitis-associated colorectal cancer, while showing no effect on inflammation, inhibits colorectal cancer progression.

    Original languageEnglish
    Pages (from-to)17146-17151
    Number of pages6
    JournalProceedings of the National Academy of Sciences of the United States of America
    Volume106
    Issue number40
    DOIs
    Publication statusPublished - 6 Oct 2009

    Cite this